Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Gastric Cancer Market Analysis 2016 - Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 27 Sep 16

Research and Markets has announced the addition of the "Global Gastric Cancer Market Analysis 2016 - Forecast to 2022" report to their offering.

This report analyzes the global markets for "Gastric Cancer". The market assessment is performed through standard and the tailored research methodology approach.

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Gastric Cancer Market by Testing Type

  • Chest X-Ray
  • Computed Tomography (CT or CAT) Scan
  • Helicobacer Pylori
  • Imaging Tests
  • Laparoscopy
  • Magnetic Resonance Imaging (MRI) Scan
  • Positron Emission Tomography (PET) Scan
  • Upper Gastrointestinal (GI) Series

6 Gastric Cancer Market by Drug Class

  • Docetaxel
  • Doxorubicin Hydrochloride
  • Fluorouracil
  • Imatinib
  • Mitomycin C
  • Sunitinib
  • Trastuzumab

7 Gastric Cancer Market by Treatment Type

  • Adjuvant chemotherapy
  • Chemo Therapy
  • Radiation therapy
  • Surgery
  • Targeted drugs therapy

8 Gastric Cancer Market by Geography

9 Vendor Landscaping

10 Company Profiles

10.1 Eli Lilly and Company

10.2 AstraZeneca Plc.

10.3 Biogen idec

10.4 Bristol Myers Squibb

10.5 F Hoffmann-La Roche

10.6 Genentech, Inc

10.7 GlaxoSmithKline

10.8 Hoffmann-la Roche inc.

10.9 Immunogen

10.10 Merck KGaA

10.11 Novartis AG

10.12 Oncolytics

10.13 Otsuka Pharmaceutical

10.14 Pacific edge diagnostics NZ

10.15 Roche Holdings AG

10.16 Sanofi-Aventis

10.17 Zova biotherapeutics Inc.

10 Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.